Experience

    • Mayfair Equity Partners in the formation of Mayfair Fund III, a £500 million fund.
    • StepStone Group in a multi-asset secondary transaction with Gyrus Capital involving Essential Pharma and dss+, both initially acquired by Gyrus Capital in 2019.